TR Flotte, SA Afione and PL Zeitlin
Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Hospital, Baltimore, Maryland 21287-2533.

Adeno-associated virus type 2 (AAV2)-based vectors are capable of stable expression in the airway epithelium and may be useful for gene therapy for human diseases, such as cystic fibrosis. Certain virus vectors, such as retroviruses, require active cell division for integration and expression, but this has not been formally evaluated in the case of AAV2. The cystic fibrosis bronchial epithelial cell line, IB3-1, which can be transduced by AAV2 vectors, was shown to undergo a decrease in DNA synthesis to undetectable levels when grown to confluence. Cultures in which < 0.1% of cells were dividing could still be efficiently transduced with AAV-lacZ or AAV-neo vectors, with a linear dose response, up to 91% with a multiplicity of 3,000 vector particles per cell. The fate of vector DNA in nondividing target cells was investigated by Southern blotting of both low molecular weight, nonintegrated DNA and high molecular weight, genomic DNA fractions. Detectable levels of vector DNA were only seen in the nonintegrated state. These results indicate that AAV2-based vectors, unlike retrovirus vectors, do not require active cell division or integration for expression to occur and thus possess a unique profile of biologic properties.

This article has been cited by other articles:

				L. Santat, H. Paz, C. Wong, L. Li, J. Macer, S. Forman, K. K. Wong, and S. Chatterjee Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice PNAS, August 2, 2005; 102(31): 11053 - 11058. [Abstract] [Full Text] [PDF]

				J. R. Mendell and A. Miller Gene transfer for neurologic disease: Agencies, policies, and process Neurology, December 28, 2004; 63(12): 2225 - 2232. [Abstract] [Full Text] [PDF]

				H. Madry, M. Cucchiarini, G. Kaul, D. Kohn, E. F. Terwilliger, and S. B. Trippel Menisci Are Efficiently Transduced by Recombinant Adeno-Associated Virus Vectors In Vitro and In Vivo Am. J. Sports Med., December 1, 2004; 32(8): 1860 - 1865. [Abstract] [Full Text] [PDF]

				T. R. Flotte, M. Humbert, E. Fadel, B. Raffestin, M. Darmon, F. Capron, G. Simonneau, P. Dartevelle, M. Hamon, and S. Adnot Recombinant Adeno-Associated Virus Gene Therapy for Cystic Fibrosis and {alpha}1-Antitrypsin Deficiency Chest, March 1, 2002; 121(2007): 98S - 102S. [Abstract] [Full Text] [PDF]

				M. Shimpo, U. Ikeda, Y. Maeda, M. Takahashi, H. Miyashita, H. Mizukami, M. Urabe, A. Kume, T. Takizawa, M. Shibuya, et al. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model Cardiovasc Res, March 1, 2002; 53(4): 993 - 1001. [Abstract] [Full Text] [PDF]

				Z. Borok, J. E. Harboe-Schmidt, S. L. Brody, Y. You, B. Zhou, X. Li, P. M. Cannon, K.-J. Kim, E. D. Crandall, and N. Kasahara Vesicular Stomatitis Virus G-Pseudotyped Lentivirus Vectors Mediate Efficient Apical Transduction of Polarized Quiescent Primary Alveolar Epithelial Cells J. Virol., December 1, 2001; 75(23): 11747 - 11754. [Abstract] [Full Text]

				T. R. Flotte and B. L. Laube Gene Therapy in Cystic Fibrosis Chest, September 1, 2001; 120(3_suppl): 124S - 131S. [Abstract] [Full Text] [PDF]

				A. K. Malik, P. E. Monahan, D. L. Allen, B.-G. Chen, R. J. Samulski, and K. Kurachi Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer J. Virol., April 15, 2000; 74(8): 3555 - 3565. [Abstract] [Full Text]

				X. Tang, D. Mohuczy, Y. C. Zhang, B. Kimura, S. M. Galli, and M. I. Phillips Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2392 - H2399. [Abstract] [Full Text] [PDF]

				S. E. Beck, L. A. Jones, K. Chesnut, S. M. Walsh, T. C. Reynolds, B. J. Carter, F. B. Askin, T. R. Flotte, and W. B. Guggino Repeated Delivery of Adeno-Associated Virus Vectors to the Rabbit Airway J. Virol., November 1, 1999; 73(11): 9446 - 9455. [Abstract] [Full Text] [PDF]

				J. Yang, W. Zhou, Y. Zhang, T. Zidon, T. Ritchie, and J. F. Engelhardt Concatamerization of Adeno-Associated Virus Circular Genomes Occurs through Intermolecular Recombination J. Virol., November 1, 1999; 73(11): 9468 - 9477. [Abstract] [Full Text] [PDF]

				M. S. LIPKOWITZ, B. HANSS, N. TULCHIN, P. D. WILSON, J. C. LANGER, M. D. ROSS, G. J. KURTZMAN, P. E. KLOTMAN, and M. E. KLOTMAN Transduction of Renal Cells in Vitro and in Vivo by Adeno-Associated Virus Gene Therapy Vectors J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1908 - 1915. [Abstract] [Full Text]

				D. Duan, P. Sharma, L. Dudus, Y. Zhang, S. Sanlioglu, Z. Yan, Y. Yue, Y. Ye, R. Lester, J. Yang, et al. Formation of Adeno-Associated Virus Circular Genomes Is Differentially Regulated by Adenovirus E4 ORF6 and E2a Gene Expression J. Virol., January 1, 1999; 73(1): 161 - 169. [Abstract] [Full Text] [PDF]

				D. Duan, P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue J. Virol., November 1, 1998; 72(11): 8568 - 8577. [Abstract] [Full Text] [PDF]

				G J CLESHAM Gene therapy made difficult Heart, October 1, 1998; 80(4): 313 - 314. [Full Text]

				X.-S. Wang, B. Khuntirat, K. Qing, S. Ponnazhagan, D. M. Kube, S. Zhou, V. J. Dwarki, and A. Srivastava Characterization of Wild-Type Adeno-Associated Virus Type 2-Like Particles Generated during Recombinant Viral Vector Production and Strategies for Their Elimination J. Virol., July 1, 1998; 72(7): 5472 - 5480. [Abstract] [Full Text] [PDF]

				F. Palombo, A. Monciotti, A. Recchia, R. Cortese, G. Ciliberto, and N. La Monica Site-Specific Integration in Mammalian Cells Mediated by a New Hybrid Baculovirus-Adeno-Associated Virus Vector J. Virol., June 1, 1998; 72(6): 5025 - 5034. [Abstract] [Full Text] [PDF]

				S. Ponnazhagan, K. A. Weigel, S. P. Raikwar, P. Mukherjee, M. C. Yoder, and A. Srivastava Recombinant Human Parvovirus B19 Vectors: Erythroid Cell-Specific Delivery and Expression of Transduced Genes J. Virol., June 1, 1998; 72(6): 5224 - 5230. [Abstract] [Full Text] [PDF]

				H. Su, R. Lu, J. C. Chang, and Y. W. Kan Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice PNAS, December 9, 1997; 94(25): 13891 - 13896. [Abstract] [Full Text] [PDF]

				Y. Maeda, U. Ikeda, Y. Ogasawara, M. Urabe, T. Takizawa, T. Saito, P. Colosi, G. Kurtzman, K. Shimada, and K. Ozawa Gene transfer into vascular cells using adeno-associated virus (AAV) vectors Cardiovasc Res, September 1, 1997; 35(3): 514 - 521. [Abstract] [Full Text] [PDF]

				P. D. Kessler, G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein PNAS, November 26, 1996; 93(24): 14082 - 14087. [Abstract] [Full Text] [PDF]

				D. S. Strayer and D. S. Strayer SV40 As an Effective Gene Transfer Vector in Vivo J. Biol. Chem., October 4, 1996; 271(40): 24741 - 24746. [Abstract] [Full Text] [PDF]